Made In India Stents Just As Good As Their International Counterparts, Study From Germany Shows

The Logical Indian Crew

November 15th, 2018 / 7:02 PM

Indian Stents

Image Credit: All India Radio News/Twitter, The Times of India

A 10-year follow-up study has concluded that Made-In-India stents are just as good as its foreign counterparts. This weakens the argument made by several trans-national firms who claimed higher prices for their products saying they are  “better in performance”.


Analysis based on a 10-year follow up study

For the study, the cardiologists at the German Heart Centre in Munich, Germany examined 2,603 patients for over a decade, as reported by Deccan Herald.

One of the three types of stents were given to patients. These three types were – Yukon Choice PC made by Indian firm Translumina at its Dehradun and Hechingen (Germany) plants, Xience manufactured by Abbott and Cypher produced by Cordis Corporation. It may be noted that the Cypher is a relatively older version of drug-eluting stents as compared to Yukon and Xience.

After a gap of 10 years, 1,827 patients out of the 2,603 are alive. The mortality rate among the group of patients using these three different stents showed much variation.

Among the three, Yukon and Xience performed at par with each other with risk reduction at 18% and 21% and mortality risk reduction at 18% and 22% respectively. Both these type of stents performed significantly better than Cypher.

Moreover, Yukon also showed the lowest rate of definite or probable stent thrombosis (a serious long-term complication caused due to drug-eluting stent), as compared with Xience and Cypher.


Capping of prices of cardiac stents

The NPPA (National Pharmaceutical Pricing Authority) capped the prices of cardiac stents (used in angioplasty procedure for heart patients) in February 2017. The authority set a ceiling of a bare metal stent to Rs 7,260 and drug-eluting stents and bioresorbable vascular scaffold/ biodegradable stents to Rs 29,600.

This decision came after the Delhi High Court asked the government to take immediate steps responding to a Public Interest Litigation (PIL) filed by Advocate Birendra Sangwan. The PIL was seeking price control of stents since many people can not afford what could probably be life-saving surgery due to high prices of stents.

A year later, the cost was further reduced by about Rs 2,200, bringing down the price to Rs 27,890.


Also Read: A Lawyer’s Fight With Hospitals Has Led To A Decrease In Heart Stent Price By 400%


Contributors

Written by : Shraddha Goled

Edited by : Shraddha Goled

Related Stories

Tuberculosis Damage Lungs

New Study Shows That TB Can Cause Permanent Lung Damage Even After Successful Treatment

Germany Moves To Brand Masood Azhar As ‘Global Terrorist’ At EU

Germany Close Coal-Fired Power Plants

Fight Against Climate Change: Germany To Shut Down All 84 Of Its Coal-Fired Power Plants By 2038

Bonded Labourers Life

Just A Loan Of Rs 1000 Made This Couple & Their Children Slaves For Years

UN Study Ozone Layer

Good News: Ozone Layer Is Recovering At The Rate Of 1 To 3 Percent Per Decade, Says UN Study

RBI Study Shows Major Fall In Rural Wages Since 2014

Latest on The Logical Indian

Health

From Losing Her Husband To Healing Hundreds Of Others, Dimple Parmar Is A Ray Of Hope For All Cancer Patients

World Affairs

Oil Prices Soar By 10% After Attacks On Saudi Reserves

World Affairs

‘Will Go Nuclear’, Pak PM Imran Khan Warns India, Muslim Nations Ask To Tone Down Rhetoric

News

Air India Posts Rs. 4600 Crore Operating Loss In 2018-19 Due To High Oil Prices, Aims Profit This Fiscal Year

News

Maharashtra ‘Plans’ First Detention Centre In Navi Mumbai, More States To Follow

News

Rajasthan Transport Authorities Cancel Dead Man’s Driving License

x

Stories that deserve attention, delivered to your inbox!

Handpicked, newsworthy stories which deserve the attention of a rational generation.